Drug
Enstilar Foam
Enstilar Foam: highest development phase Post-Market, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Enstilar Foam NCT04227288 | Post-Market | Nail Psoriasis |
Latest
No recent events.
Follow Enstilar Foam on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.